• In late April 2026, AXT, Inc. reported first-quarter 2026 results showing sales of US$26.92 million, a much smaller net loss of US$1.62 million, and the completion of a roughly US$550.00 million follow-on share offering to fund expansion of its semiconductor substrate operations.
• Beyond the headline growth, AXT highlighted surging demand and a record backlog for indium phosphide substrates used in AI-focused data centers, underlining its role in easing a key supply bottleneck for next-generation optical connectivity.
• We’ll now examine how this capacity expansion funded by the recent equity raise could reshape AXT’s investment narrative in AI infrastructure.

We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

AXT Investment Narrative Recap

To own AXT, you have to believe that its indium phosphide substrates sit at the heart of AI data center build‑outs and that the company can translate today’s record backlog into sustainable, profitable growth. The key short term catalyst is execution on its aggressive InP capacity ramp, while the biggest risk remains export permit timing and geopolitical constraints that could delay shipments. The latest results and equity raise do not remove this risk, but they do strengthen AXT’s ability to fund expansion.

The recent completion of AXT’s roughly US$550.00 million follow‑on equity offering is central to this story, because it underpins the planned doubling of indium phosphide capacity in 2026 and again in 2027. That capital, alongside the reported US$26.92 million in Q1 sales and sharply narrower net loss, ties directly to the company’s effort to ease AI‑related supply bottlenecks and potentially shift its earnings profile if export approvals and customer demand materialize as expected.

Yet beneath the AI growth story, investors should be aware of how export permits and geopolitics could still...

AXT's narrative projects $238.5 million revenue and $62.6 million earnings by 2029.

Uncover how AXT's forecasts yield a $30.75 fair value, a 68% downside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already modeling revenues near US$300 million and earnings above US$100 million, which is far more bullish than consensus. If you believe export constraints can ease while demand for indium phosphide stays robust, their view might feel closer to your own, but the latest capital raise and backlog data could still push those expectations higher or lower once everyone updates their models.

Explore 5 other fair value estimates on AXT - why the stock might be worth less than half the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your AXT research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free AXT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate AXT's overall financial health at a glance.

Looking For Alternative Opportunities?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Find 50 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.